Tamoxifen induces oxidative stress and apoptosis in oestrogen receptor-negative human cancer cell lines

British Journal of Cancer

Volumn 79, Issue 2, 1999, Pages 257-263

  Ferlini, C ^a   Scambia, G ^a   Marone, M ^a   Distefano, M ^a   Gaggini, C ^a   Ferrandina, G ^a   Fattorossi, A ^a   Isola, G ^a   Panici, P Benedetti ^a   Mancuso, S ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Apoptosis; NF B; Oxidative stress; Tamoxifen

Indexed keywords

DNA; ESTROGEN RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TAMOXIFEN; THIOL;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; OVARY CANCER; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 0032918850     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690042     Document Type: Article

References (30)

1. Bass DA, Parce JW, Dechatelet LR, Szejda P, Seeds MC and Thomas M (1983) Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol 130: 1910-1917
2. Berman E, Adams M, Duigou-Ostendorf R, Godfrey L, Clarkson B and Andreef M (1991) Effect of tamoxifen on cell lines displaying the multidrug-resistant phenotype. Blood 77: 818-825
3. Couldwell WT, Hinton DR, He S, Chen TC, Sebat I, Weiss MH and Law RE (1994) Protein kinase C inhibitors induce apoptosis in human malignant glioma cell lines. FEBS Lett 345: 43-46
4. De Vincenzo R, Scambia G, Benedetti Panici P, Fattorossi A, Bonanno G, Ferlini C, Isola G, Pernisco S and Mancuso S (1996) Modulatory effect of tamoxifen and ICI 182,780 on adriamycin resistance in MCF-7 human breast cancer cells. Int J Cancer 68: 340-348
5. Ferlini C, Biselli R, Scambia G and Fattorossi A (1996) Probing chromatin structure in the early phases of apoptosis. Cell Prolif 29: 427-436
6. Ferlini C, Scambia G, Distefano M, Bombardelli E, Riva A, Fattorossi A, Filippini P, Isola G, Benedetti Panici P and Mancuso S (1997) Synergistic antiproliferative activity of tamoxifen and docetaxel on three oestrogen receptor negative cancer cell lines is mediated by the induction of apoptosis. Br J Cancer 75: 884-891
7. Gosland M, Lum B, Schimmelpfennig J, Baker J and Doukas M (1996) Insights into mechanisms of cisplatin resistance and potential for its clinical reversal. Pharmacotherapy 16: 16-39
8. Gundimeda U, Chen ZH and Gopalakrishna R (1996) Tamoxifen modulates protein kinase C via oxidative stress in estrogen receptor-negative breast cancer cells. J Biol Chem 271: 13504-13514
9. Haldar S, Jena N and Croce CM (1995) Inactivation of Bcl-2 by phosphorylation. Proc Natl Acad Sci USA 92: 4507-4511
10. Haldar S, Chintapalli J and Croce CM (1996) Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res 56: 1253-1255
11. Hockenbery DM, Oltvai ZN, Xiao-Ming Y, Milliman CL and Korsmeyer SJ (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75: 241-251
12. Issandou M, Faucher C, Bayard F and Darbon JM (1990) Opposite effects of tamoxifen on in vitro protein kinase C activity and endogenous protein phosphorylation in intact MCF-7 cells. Cancer Res 50: 5845-5850
13. Jaiyesimi IA, Buzdar AU, Decker DA and Hortobagyi GN (1995) Use of tamoxifen for breast cancer: twenty-eight years later. J Clin Oncol 13: 513-529
14. Janssen YM, Barchowsky A, Treadwell M, Driscoll KE and Mossman BT (1995) Asbestos induces nuclear factor kappa B (NF-kappa B) DNA-binding activity and NF-kappa B-dependent gene expression in tracheal epithelial cells. Proc Natl Acad Sci 92: 8458-8462
15. Kang Y and Perry RR (1993) Modulatory effects of tamoxifen and recombinant human α-interferon on doxorubicin resistance. Cancer Res 53: 3040-3045
16. Kang Y, Cortina R and Perry RR (1996) Role of c-myc in tamoxifen-induced apoptosis in estrogen-independent breast cancer cells. J Natl Cancer Inst 88: 279-284
17. Kirk K, Houlbrook S, Stuart NSA, Stratford IJ, Harris AL and Carmichael J (1993) Differential modulation of doxorubicin to multidrug and intrinsically drug-resistant cell lines by anti-oestrogens and their major metabolites. Br J Cancer 67: 1189-1195
18. Leonessa F, Jacobson M, Boyle B, Lippman J, McGarvey M and Clarke R (1994) Effect of tamoxifen on the multidrug-resistant phenotype in human breast cancer cells: isobologram, drug accumulation and Mr 170 000 glycoprotein (gp 170) binding studies. Cancer Res 54: 441-147
19. Lopes MCF, Vale MGP and Caravalho AP (1990) Ca-dependent binding of tamoxifen to calmodulin isolated from bovine brain. Cancer Res 50: 2753-2758
20. Los M, Droge W, Stricker K, Bauerle PA and Schulze-Osthoff K (1995) Hydrogen peroxide as a potent activator of T lymphocyte functions. Eur J Immunol 25: 159-165
21. McClay EF, Albright KD, Jones JA, Christen RD and Howell SB (1993) Tamoxifen modulation of cisplatin sensitivity in human malignant melanoma cells. Cancer Res 53: 1571-1576
22. McClay EF, Jones JA, Winski PJ, Albright KD, Christen RD and Howell SB (1996) Determinants of tamoxifen sensitivity control the nature of the synergistic interaction between tamoxifen and cisplatin. Cancer Res 56: 3993-3997
23. Murrell GA, Francis MJ and Bromley L (1990) Modulation of fibroblast proliferation by oxygen free radicals. Biochem J 265: 659-665
24. Perry RR, Kang Y and Greaves B (1995) Effects of tamoxifen on growth and apoptosis of oestrogen-dependent and -independent human breast cancer cells. Ann Surg Oncol 2: 238-245
25. Poot M, Kavanagh TJ, Kang HC, Haugland RP and Rabinovitch PS (1991) Flow cytometric analysis of cell-cycle dependent changes in thiol level by combining a new laser dye with Hoechst 33342. Cytometry 12: 184-187
26. Rao GN and Berk BC (1992) Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ Res 70: 593-599
27. Sen CK und Packer L (1996) Antioxidant and redox regulation of gene transcription. FASEB J 10: 709-720
28. Wiseman H (1993) Protective actions of tamoxifen and 4-hydroxytamoxifen against oxidative damage to human low-density lipoproteins: a mechanism accounting for the cardioprotective action of tamoxifen? Biochem J 292: 635-638
29. Wiseman H, Laughton MJ, Arnstein HRV, Cannon M and Halliwell B (1990) The antioxidant action of tamoxifen. Inhibition of lipid peroxidation. FEBS Lett 263: 192-194
30. Ye Q and Bodell WJ (1996) Production of 8-hydroxy-2′-deoxyguanosine in DNA by microsomal activation of tamoxifen and 4-hydroxytamoxifen. Carcinogenesis 17: 1747-1750